What started off as an importer of Ford cars in 1913, Empire Motor Co. has become a vital supplier of maintenance parts for Japanese automotive industry. With the ever-changing of cars, Empire has been ensuring that is keeps up with industry demand, supplying products for the upcoming EV era of vehicles. In this interview, President Atsushi Kamihashi discusses Empire Motor’s long history and how it is adapting to the demands of a modern world
What started off as an importer of Ford cars in 1913, Empire Motor Co. has become a vital supplier of maintenance parts for Japanese automotive industry. With the ever-changing of cars, Empire has been ensuring that is keeps up with industry demand, supplying products for the upcoming EV era of vehicles. In this interview, President Atsushi Kamihashi discusses Empire Motor’s long history and how it is adapting to the demands of a modern world
Leveraging more than a century of experience in industrial jewel processing, Ogura Jewel Industry remains among the excellent SMEs in Japan today, maintaining an influential position as a precision manufacturer of wire guides, coating dies, diamond styluses, among other devices.
Leveraging more than a century of experience in industrial jewel processing, Ogura Jewel Industry remains among the excellent SMEs in Japan today, maintaining an influential position as a precision manufacturer of wire guides, coating dies, diamond styluses, among other devices.
Mitsubishi Tanabe Pharma Corporation (MTPC), a wholly owned subsidiary of Mitsubishi Chemical Holdings Group, has proudly pursued medical breakthroughs for more than 300 years. In that time, the company has discovered several distinctive treatments for serious diseases including diabetes and multiple sclerosis. While these successes represent a strong part of its corporate identity, MTPC continues to build on its legacy by seeking new solutions to the pressing needs of patients worldwide. Today, MTPC is focused on driving scientific discovery in areas including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and – most recently – a novel vaccine for COVID-19.
Mitsubishi Tanabe Pharma Corporation (MTPC), a wholly owned subsidiary of Mitsubishi Chemical Holdings Group, has proudly pursued medical breakthroughs for more than 300 years. In that time, the company has discovered several distinctive treatments for serious diseases including diabetes and multiple sclerosis. While these successes represent a strong part of its corporate identity, MTPC continues to build on its legacy by seeking new solutions to the pressing needs of patients worldwide. Today, MTPC is focused on driving scientific discovery in areas including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and – most recently – a novel vaccine for COVID-19.
Founded in 1974, Shinkoh Electronics has been at the heart of the semiconductor industry for nearly half a century. In that time, a number of changes have occurred. Where companies such as Toshiba and Mitsubishi were once global leaders in semiconductor manufacturing, the last two decades have seen a shift in focus. Japanese companies are no longer making semiconductors themselves, but embedding semiconductors purchased overseas into their products. “This,” says company president and CEO, Hideo Sakaki, “is the new standard.” Faced with a series of challenges, Shinkoh is staging a recovery and looking to the future as it prepares to launch a new line of products to coincide with its 50th anniversary.
Founded in 1974, Shinkoh Electronics has been at the heart of the semiconductor industry for nearly half a century. In that time, a number of changes have occurred. Where companies such as Toshiba and Mitsubishi were once global leaders in semiconductor manufacturing, the last two decades have seen a shift in focus. Japanese companies are no longer making semiconductors themselves, but embedding semiconductors purchased overseas into their products. “This,” says company president and CEO, Hideo Sakaki, “is the new standard.” Faced with a series of challenges, Shinkoh is staging a recovery and looking to the future as it prepares to launch a new line of products to coincide with its 50th anniversary.
Founded in 1926, Takebishi focuses on three main sectors: industrial equipment and systems; semiconductor and devices; and social/information communications. It has developed the ability to provide components from Japanese heavyweights like Mitsubishi and Omron and embed them into total solutions for its customers, essentially acting as the client’s purchasing and design departments. By combining its innovative products with those of Japanese manufacturing giants such as Mitsubishi, Takebishi Corporation is pushing the trading world forward by providing total solutions.
Founded in 1926, Takebishi focuses on three main sectors: industrial equipment and systems; semiconductor and devices; and social/information communications. It has developed the ability to provide components from Japanese heavyweights like Mitsubishi and Omron and embed them into total solutions for its customers, essentially acting as the client’s purchasing and design departments. By combining its innovative products with those of Japanese manufacturing giants such as Mitsubishi, Takebishi Corporation is pushing the trading world forward by providing total solutions.
An urakata – or backstage – company specializing in the highly specific mass finishing industry, Tipton was established in 1939. Initially a manufacturer of grinding wheels and abrasive media, the corporation has since diversified into machinery and chemical compounds. “The ability to design, produce and sell all these factors – the machinery, the abrasive media and the chemical compounds – has given us a unique position in the market as an integrated solutions provider for mass finishing,” says company president Fumiaki Kobayashi.
An urakata – or backstage – company specializing in the highly specific mass finishing industry, Tipton was established in 1939. Initially a manufacturer of grinding wheels and abrasive media, the corporation has since diversified into machinery and chemical compounds. “The ability to design, produce and sell all these factors – the machinery, the abrasive media and the chemical compounds – has given us a unique position in the market as an integrated solutions provider for mass finishing,” says company president Fumiaki Kobayashi.
Since its founding in 1963, Yamahachi Dental has focused on creating high-performance but affordable artificial teeth, gaining an international reputation and being named in 2020 as a Global Top 100 Niche Company by METI (Japan’s Ministry of Economy, Trade and Industry). With the second largest production capacity of artificial teeth in the world, Yamahachi Dental is supplying smiles across the globe.
Since its founding in 1963, Yamahachi Dental has focused on creating high-performance but affordable artificial teeth, gaining an international reputation and being named in 2020 as a Global Top 100 Niche Company by METI (Japan’s Ministry of Economy, Trade and Industry). With the second largest production capacity of artificial teeth in the world, Yamahachi Dental is supplying smiles across the globe.
A company best known for its PAL series of handheld measuring instruments, ATAGO specializes in refractometers designed to determine the Brix, or sugar content, of substances. ATAGO’s most popular refractometer is the PAL-1, a device typically used to gauge the Brix of fruit, vegetables, jams, sauces, condiments, soups and drinks. In this interview, president Hideyuki Amamiya gives more insight into the company and its technology, and explains how ATAGO closely listens to what its customers want in order to create well-designed, easy-to-use products.
A company best known for its PAL series of handheld measuring instruments, ATAGO specializes in refractometers designed to determine the Brix, or sugar content, of substances. ATAGO’s most popular refractometer is the PAL-1, a device typically used to gauge the Brix of fruit, vegetables, jams, sauces, condiments, soups and drinks. In this interview, president Hideyuki Amamiya gives more insight into the company and its technology, and explains how ATAGO closely listens to what its customers want in order to create well-designed, easy-to-use products.
Automation is increasingly empowering health providers to offer better services, including increased efficiency and better patient management. We spoke to Tosho president Yoshihito Omura to learn more about how the Japanese manufacturer is leading the way in Japan with its range of automated solutions while seeking to break into international markets.
Automation is increasingly empowering health providers to offer better services, including increased efficiency and better patient management. We spoke to Tosho president Yoshihito Omura to learn more about how the Japanese manufacturer is leading the way in Japan with its range of automated solutions while seeking to break into international markets.
Antibiotic-resistant bacteria (ARB) has become a global healthcare crisis, with as many as 700,000 people worldwide dying annually due to the growing problem. Japanese firm Miyarisan Pharmaceutical is leading the pack in the research and development of probiotics to treat the issue. We spoke to president Masayuki Uchida to learn more about Miyarisan's activities at the forefront of healthcare.
Antibiotic-resistant bacteria (ARB) has become a global healthcare crisis, with as many as 700,000 people worldwide dying annually due to the growing problem. Japanese firm Miyarisan Pharmaceutical is leading the pack in the research and development of probiotics to treat the issue. We spoke to president Masayuki Uchida to learn more about Miyarisan's activities at the forefront of healthcare.
